Connect with us

drug

CJ CheilJedang, and Emmyon, Inc. signal a Licensing Agreement to commercialize a dietary complement with pure extracts to be used in important enchancment of skeletal muscle mass and performance in people.

Published

on


SEOUL, South Korea and ROCHESTER, Minn., Dec. 26, 2022 /PRNewswire/ — CJ Meals and Vitamin Tech (CJ FNT), a newly shaped enterprise unit of CJ CheilJedang, a South Korea primarily based international meals and vitamin firm, and Emmyon, Inc., a privately-held biotechnology start-up firm primarily based in Rochester, MN USA, have signed an unique licensing settlement establishing a strategic partnership between the 2 organizations.

A signing ceremony and keynote speeches had been held on December 6th, 2022 at CJ CheilJedang’s international headquarters in Seoul, South Korea attended by the CEOs and senior executives of each CJ CheilJedang and Emmyon to commemorate the event.   

The technical and industrial collaboration will end result within the international launch of a number of nutraceutical and dietary complement merchandise which have the flexibility to inhibit muscle atrophy whereas enhancing power and endurance. Skeletal muscle atrophy, also called muscle losing or sarcopenia within the aged, is a widespread and severe situation that impacts tens of hundreds of thousands of individuals world wide and due to this fact represents an infinite unmet medical want.  It notably impacts older individuals with arthritis, on mattress relaxation as a result of physique accidents corresponding to unintentional falls and malnutrition by way of sicknesses corresponding to most cancers. Optimum muscle well being can also be necessary in sports activities efficiency and lack of bodily train the place dietary supplementation might be useful.

The licenses handled Emmyon are protected by an intensive portfolio of unique patents within the USA, Europe and different key jurisdictions which will probably be leveraged by way of CJ FNT’s international industrial know-how and advertising and marketing power.

Emmyon Founder, CEO and President, Dr. Christopher Adams, a number one physician-scientist expressed his nice enthusiasm for this landmark deal which might doubtlessly profit hundreds of thousands of individuals within the U.S., and elsewhere. Dr. Adams is Professor of Medication, Clinician Investigator, and Analysis Chair of the Division of Endocrinology, Diabetes, Metabolism and Vitamin at Mayo Clinic. His analysis focuses on mechanisms and therapy of muscle atrophy and diabetes. His scientific observe focuses on the care of sufferers with diabetes and different endocrine issues.

Different key members of the administration group at Emmyon embody Scott Ebert, PhD, a extremely achieved skeletal muscle biologist who’s an Assistant Professor at Mayo Clinic, and John J. Talley, PhD, one of many world’s preeminent medicinal chemists. In 2015-2019 and in 2021, Dr. Talley was named to The Medication Maker Energy checklist, which acknowledges the world’s most influential individuals in drug discovery and growth.

Head of CJ FNT, Lance Choi, underlined his firm’s dedication to innovation, progress, and advertising and marketing excellence within the subject of human vitamin. This has resulted in main investments in analysis and growth, manufacturing capabilities and an emphasis on forging key partnerships corresponding to that with Emmyon to convey new scientific discoveries in dietary science to market. This landmark deal marks the start of a serious push for the corporate into the sector of muscle well being and metabolism with the objective of world market management on this class.

For extra info, go to: https://www.cjbio.internet/   and www.emmyon.com

About CJ Meals and Vitamin Tech  
CJ Meals and Vitamin Expertise, a enterprise unit of CJ CheilJedang, is part of CJ Group, South Korea’s preeminent firm within the fields of Meals & Meals Service, Bio & Pharma, Leisure & Media, and Retail & Logistics.
CJ Meals and Vitamin Expertise is a number one provider of fermentation-based bio-products corresponding to an intensive line of ‘AMINATURE®‘ amino acids for human vitamin at its multi-national manufacturing services worldwide.

About Emmyon, Inc.
Emmyon is a non-public biotechnology firm with a concentrate on optimum skeletal muscle well being. It investigates how growing old, sickness and harm trigger muscle atrophy. It then makes use of that information to find small molecules that enhance muscle power, mass and metabolism. These small molecules are supposed to create new meals merchandise for muscle well being, whereas others are being developed as prescribed drugs for weight problems and kind 2 diabetes.

SOURCE CJ CheilJedang



Supply hyperlink

drug

Experts slam Kourtney Kardashian for selling 'harmful pseudoscience' as she says her $400 placenta capsule – Daily Mail

Published

on

By

Continue Reading

drug

Kyowa Hakko educates dieticians and nutritionists about mind … – Nutritional Outlook

Published

on

By

Continue Reading

drug

Dietary Supplement & Cosmetics Legal Bulletin | November 2023 … – JD Supra

Published

on

By

Continue Reading

Trending

Copyright © 2017 Zox News Theme. Theme by MVP Themes, powered by WordPress.